CALCA and metabolic disease: Although we did not detect significant alterations in serum levels of Calca-derived peptides during DIO (S1a Fig), this study for the first time provides a comparative analysis regarding the roles of PCT, CT and αCGRP in obesity and metabolic disease using mouse models deficient in Calca, CTR, and αCGRP.